Search results

Ongoing media statements relating to nuclear medicine production.

ANSTO is contributing to key critical minerals projects funded by the Federal Government.

Best and brightest recognised in 2017 research awards

The 2023 Australian Synchrotron Stephen Wilkins Thesis Medal has been awarded to Dr Yanxiang Meng from the Walter & Eliza Hall Institute for Medical Research and the University of Melbourne for his research investigating the molecular mechanism at work in a form of programmed cell death, which is implicated in a variety of inflammatory diseases.

ANSTO is collaborating on a project funded with an Australian Research Council linkage grant that will develop new materials and better systems for efficiently storing hydrogen gas.

The Australian Synchrotron has an on-site Guesthouse for users and AS guests.

ANSTO contributes to new international project to improve how the world assesses the economic viability of Small Modular Reactors

The Detection & Imaging group builds on ANSTO’s 70-year history of scientific achievements and contributions in meeting the nuclear needs of industry, globally.

ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.

ANSTO plays a leading role in measuring and characterising fine particles from a range of locations around Australia and internationally.

Professor of Soil Science at The University of Queensland, Peter Kopittke and partner investigator Prof Enzo Lombi of the University of SA are very optimistic about the use of a new synchrotron-based imaging technique that captures in 3D the complex interaction of soil and root.

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

Two approaches use existing low cost and low energy technologies to reuse stockpiled waste from mining operations - capturing carbon dioxide in the form of valuable carbonate minerals.

ANSTO provides a range of capabilities using neutrons, X-rays and infrared radiation to study the solids, liquids and gases that might be found in materials in our solar system and beyond.

Applied Molecular Therapies (AMT) has announced a successful TGA licence upgrade for the GMP manufacture of an emerging prostate cancer therapy, following the launch of a new joint venture between Cyclotek and ANSTO.

The new Micro Computed Tomography (MCT) beamline is the first instrument to become operational as part of the $94 million Project BRIGHT program, which will see the completion of eight new beamlines at ANSTO’s Australian Synchrotron.

Atomic structure of new cathode material for sodium ion batteries helps explain long life

The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.

Creating a global energy system that is both environmentally and economically sustainable is unquestionably one of the largest challenges facing the scientific and engineering communities.